HCA Healthcare Inc (HCA) Shares Bought by Smithfield Trust Co.
Smithfield Trust Co. raised its stake in HCA Healthcare Inc (NYSE:HCA) by 41.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,405 shares of the company’s stock after buying an additional 410 shares during the period. Smithfield Trust Co.’s holdings in HCA Healthcare were worth $196,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of HCA. FMR LLC boosted its position in HCA Healthcare by 54.9% in the second quarter. FMR LLC now owns 5,488,273 shares of the company’s stock valued at $563,097,000 after buying an additional 1,944,961 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its position in HCA Healthcare by 98.3% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,767,715 shares of the company’s stock valued at $245,925,000 after buying an additional 876,226 shares in the last quarter. Renaissance Technologies LLC boosted its position in HCA Healthcare by 187.9% in the second quarter. Renaissance Technologies LLC now owns 1,094,431 shares of the company’s stock valued at $112,289,000 after buying an additional 714,331 shares in the last quarter. LSV Asset Management boosted its position in HCA Healthcare by 9.2% in the second quarter. LSV Asset Management now owns 5,459,388 shares of the company’s stock valued at $560,133,000 after buying an additional 457,752 shares in the last quarter. Finally, Acadian Asset Management LLC boosted its position in HCA Healthcare by 213.7% in the third quarter. Acadian Asset Management LLC now owns 645,679 shares of the company’s stock valued at $89,830,000 after buying an additional 439,826 shares in the last quarter. Hedge funds and other institutional investors own 70.84% of the company’s stock.
In related news, SVP Deborah M. Reiner sold 723 shares of HCA Healthcare stock in a transaction on Monday, November 5th. The shares were sold at an average price of $135.06, for a total transaction of $97,648.38. Following the completion of the transaction, the senior vice president now owns 6,184 shares of the company’s stock, valued at $835,211.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Jane D. Englebright sold 6,543 shares of HCA Healthcare stock in a transaction on Wednesday, August 15th. The stock was sold at an average price of $129.86, for a total transaction of $849,673.98. Following the transaction, the senior vice president now directly owns 7,443 shares of the company’s stock, valued at approximately $966,547.98. The disclosure for this sale can be found here. Insiders have sold 22,486 shares of company stock valued at $3,079,086 in the last three months. 2.80% of the stock is owned by insiders.
Shares of NYSE HCA opened at $143.95 on Friday. HCA Healthcare Inc has a twelve month low of $74.26 and a twelve month high of $144.18. The firm has a market cap of $48.75 billion, a P/E ratio of 15.92, a PEG ratio of 1.24 and a beta of 0.48.
HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, October 30th. The company reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.23. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The business had revenue of $11.45 billion during the quarter, compared to the consensus estimate of $11.29 billion. During the same quarter last year, the firm earned $1.13 earnings per share. HCA Healthcare’s quarterly revenue was up 7.1% on a year-over-year basis. On average, analysts expect that HCA Healthcare Inc will post 9.35 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, December 28th. Investors of record on Monday, December 3rd will be paid a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date of this dividend is Friday, November 30th. HCA Healthcare’s dividend payout ratio is presently 21.24%.
WARNING: “HCA Healthcare Inc (HCA) Shares Bought by Smithfield Trust Co.” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another publication, it was copied illegally and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece can be viewed at https://www.thecerbatgem.com/2018/11/10/hca-healthcare-inc-hca-shares-bought-by-smithfield-trust-co.html.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Recommended Story: What is the yield curve?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.